SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Jerry D)
 

Sökning: WFRF:(Jerry D) > Can probiotics modu...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004288naa a2200469 4500
001oai:DiVA.org:oru-55041
003SwePub
008170310s2017 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-550412 URI
024a https://doi.org/10.1017/S00071145160040372 DOI
040 a (SwePub)oru
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a for2 swepub-publicationtype
100a Bron, Peter A.u NIZO Food Research, Ede, The Netherlands; BE-Basic Foundation, The Netherlands, Delft, The Netherlands4 aut
2451 0a Can probiotics modulate human disease by impacting intestinal barrier function?
264 1a Cambridge, United Kingdom :b Cambridge University Press,c 2017
338 a print2 rdacarrier
500 a Funding Agencies:ILSI Europe Probiotic Task ForceFNRSFrench Cancer Research Association (ARC)Fonds de la Recherche Scientifique - FNRS  WELBIO-CR-2012S-02RFunds InBev-Baillet LatourERC Starting GrantEuropean Research Council, Starting grant  336452-ENIGMO
520 a Intestinal barrier integrity is a prerequisite for homeostasis of mucosal function, which is balanced to maximise absorptive capacity, while maintaining efficient defensive reactions against chemical and microbial challenges. Evidence is mounting that disruption of epithelial barrier integrity is one of the major aetiological factors associated with several gastrointestinal diseases, including infection by pathogens, obesity and diabetes, necrotising enterocolitis, irritable bowel syndrome and inflammatory bowel disease. The notion that specific probiotic bacterial strains can affect barrier integrity fuelled research in which in vitro cell lines, animal models and clinical trials are used to assess whether probiotics can revert the diseased state back to homeostasis and health. This review catalogues and categorises the lines of evidence available in literature for the role of probiotics in epithelial integrity and, consequently, their beneficial effect for the reduction of gastrointestinal disease symptoms.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Näringslära0 (SwePub)303042 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nutrition and Dietetics0 (SwePub)303042 hsv//eng
653 a Probiotics
653 a Gut microbiota
653 a Gut barrier
653 a Immunity
653 a Gastrointestinal disorders
700a Kleerebezem, Michielu Host Microbe Interactomics Group, Wageningen University, Wageningen, The Netherlands4 aut
700a Brummer, Robert-Jan,d 1957-u Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län4 aut0 (Swepub:oru)rnbr
700a Cani, Patrice D.u Metabolism and Nutrition Research Group, WELBIO – Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium4 aut
700a Mercenier, Annicku Nutrition and Health Research, Nestlé Research Center, Lausanne, Switzerland4 aut
700a MacDonald, Thomas T.u Barts and The London school of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK4 aut
700a Garcia-Ródenas, Clara Lu Nutrition and Health Research, Nestlé Research Center, Lausanne, Switzerland4 aut
700a Wells, Jerry M.u Host Microbe Interactomics Group, Wageningen University, Wageningen, The Netherlands4 aut
710a NIZO Food Research, Ede, The Netherlands; BE-Basic Foundation, The Netherlands, Delft, The Netherlandsb Host Microbe Interactomics Group, Wageningen University, Wageningen, The Netherlands4 org
773t British Journal of Nutritiond Cambridge, United Kingdom : Cambridge University Pressg 117:1, s. 93-107q 117:1<93-107x 0007-1145x 1475-2662
856u https://doi.org/10.1017/S0007114516004037y Fulltext
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-55041
8564 8u https://doi.org/10.1017/S0007114516004037

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy